missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. 18278195

Novus Biologicals™ KA1/GRIK4/Glutamate Receptor KA1 Antibody Blocking Peptide

Product Code. 18278195 Shop All Bio Techne Products
Change view
Click to view available options
Quantity:
0.05 mg
Unit Size:
0.05mg
Product Code. Quantity unitSize
18278195 0.05 mg 0.05mg
1 options
This item is not returnable. View return policy

Product Code. 18278195

Brand: Novus Biologicals™ NBP176852PEP

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 14 amino acids near the amino terminus of human Grik4. Source: Synthetic (Accession #: Q16099) The KA1/GRIK4/Glutamate Receptor KA1 Blocking Peptide has been validated for the following applications: Antibody Competition.
TRUSTED_SUSTAINABILITY

Specifications

Gene ID (Entrez) 2900
Species Human
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-76852. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias EAA1, Excitatory amino acid receptor 1, glutamate receptor KA1, Glutamate receptor KA-1, glutamate receptor, ionotropic kainate 4, glutamate receptor, ionotropic, kainate 4, KA1GRIK
Gene Symbol GRIK4
Product Type KA1/GRIK4/Glutamate Receptor KA1
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Termination 14 amino acids near the amino terminus of human Grik4
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.